News
Drug enforcement agencies across the nation play a crucial role in fighting the drug epidemic.The High Intensity Drug ...
While their functions are diverse, myosins are similar in structure. NMII is so much like cardiac myosin, which keeps the ...
A slower ramp-up of Kisunla dosing lowers the rate of dangerous brain swelling, a risk that has made doctors reluctant to ...
The U.S. Food and Drug Administration approved changing the prescribing information for Eli Lilly's Alzheimer's drug Kisunla to allow more gradual dosing to lower the risk of a potentially dangerous ...
The benefit-risk balance is tipping more in favor of Eli Lilly’s Kisunla in early Alzheimer’s disease as the FDA ...
Adcentrx Therapeutics ("Adcentrx"), a clinical-stage biotechnology company redefining Antibody-Drug Conjugate (ADC) therapies for cancer treatment and other life-threatening diseases, today announced ...
Interest in the anti-parasitic drug ivermectin skyrocketed during the covid-19 pandemic, but evidence for many of its ...
Boston Scientific announced the FDA approval of expanded labeling for its pulsed field ablation system which now includes ...
Ativan, also known by its generic name lorazepam, is a prescription medication commonly used to treat anxiety disorder, insomnia, and seizures. If you or a family member has been prescribed […] ...
Officials in Detroit, Michigan, are issuing an urgent warning over an increasingly common drug thought to be 100 times ...
1d
Zacks Investment Research on MSNDNLI's BLA for Hunter Syndrome Drug Gets FDA's Priority ReviewDenali Therapeutics, Inc. DNLI announced that the FDA has accepted for review its biologics license application (BLA) for ...
Syndax now has two approved therapies, but the share price remains under pressure despite these milestones. See why SNDX ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results